Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Targeting Interleukin-2 to the Bone Marrow Stroma for Therapy of Acute Myeloid Leukemia Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation

Christoph Schliemann, MD, Katrin Gutbrodt, PhD, Andrea Kerkhoff, MD, Michele Pohlen, MD, Stefanie Wiebe, MD, Gerda Silling, MD, Linus Angenendt, Torsten Kessler, MD, Rolf M Mesters, MD, Leonardo Giovannoni, PhD, Michael Schäfers, MD, Bianca Altvater, PhD, Claudia Rössig, MD, Inga Grünewald, MD, Eva Wardelmann, MD, Gabriele Köhler, MD, Dario Neri, PhD, Matthias Stelljes, MD, Wolfgang E Berdel, MD

Blood (2014) 124 (21): 980.

https://doi.org/10.1182/blood.V124.21.980.980

Published: 2014

Journal Articles

Control of Multidrug Resistant Pseudomonas Aeruginosa through Hospital Construction Design and Extensive Environmental and Clinical Surveillance in an Allogeneic Transplantat Unit

Annelene Kossow, MD, Frank Kipp, MD, Gerda Silling, MD, Andreas H Groll, MD, Claudia Rössig, MD, Heribert Jürgens, MD, Alexander Mellmann, MD, Helge Karch, MD, Wolfgang E Berdel, MD, Matthias Stelljes, MD

Blood (2014) 124 (21): 1137.

https://doi.org/10.1182/blood.V124.21.1137.1137

Published: 2014

Journal Articles

Comparison Of Different Pretransplant Predictive Scores In Patients With Refractory Acute Myeloid Leukemia After Allogeneic Stem Cell Transplantation Including Highdose Melphalan: Results Of a Double-Center Observational Study

Nina Kristin Steckel, M.D., Markus Ditschkowski, MD, Christoph Groth, M.D., Gerda Silling, MD, U. Krug, MD, Rudolf Trenschel, MD, Hellmut Ottinger, MD, Wolfgang E Berdel, MD, Michael Koldehoff, MD, Ahmet H. Elmaagacli, Dietrich Beelen, MD, Matthias Stelljes, MD

Blood (2013) 122 (21): 4525.

https://doi.org/10.1182/blood.V122.21.4525.4525

Published: 2013

Journal Articles

Acute Myeloid Leukemia: Longterm Outcome Predicted by Age and Genetic Groups

Thomas Buchner, MD, Wolfgang E. Berdel, MD, Utz Krug, Claudia Haferlach, MD, Susanne Schnittger, PhD, Matthias Stelljes, MD, Gerda Silling, MD, Peter Staib, MD, Andreas Grueneisen, MD, Albrecht Reichle, Leopold Balleisen, MD, Hartmut Eimermacher, MD, Aristoteles Giagounidis, MD, Herbert Rasche, MD, Eva Lengfelder, MD, Cristina Sauerland, MSc, Achim Heinecke, PhD, Bernhard Josef Woermann, MD, Wolfgang Hiddemann, MD, PhD

Blood (2012) 120 (21): 1509.

https://doi.org/10.1182/blood.V120.21.1509.1509

Published: 2012

Journal Articles

Testing G-CSF responsiveness predicts the individual susceptibility to infection and consecutive treatment in recipients of high-dose chemotherapy

Blood (2011) 117 (7): 2121–2128.

https://doi.org/10.1182/blood-2010-06-290080

Published: 2011

Journal Articles

Dose Escalation of Caspofungin for Invasive Aspergillosis - A Phase II Trial

O. A Cornely, J. J Vehreschild, M. J Rüping, S. Schwartz, C. Heussel, Gerda Silling, MD, J. Franklin, F. Farowski, T. Lehrnbecher, A. J Ullmann, A. Groll, Meinolf Karthaus

Blood (2010) 116 (21): 2309.

https://doi.org/10.1182/blood.V116.21.2309.2309

Published: 2010

Journal Articles

Forty-One Recent Cases of Invasive Zygomycosis From a Global Clinical Registry.

Blood (2009) 114 (22): 4736.

https://doi.org/10.1182/blood.V114.22.4736.4736

Published: 2009

Journal Articles

Immunological Intervention Triggered by Decreasing CD34 + Lineage-Specific Donor Cell Chimerism to Prevent Relapse of Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT).

Felix Rosenow, Gerda Silling, MD, Berkemeier Almut, MD, Carsten Mueller-Tidow, MD, Steffen Koschmieder, MD, Guido Bisping, MD, Utz Krug, MD, Thomas Buechner, MD, Wolfgang E Berdel, MD, Joachim Kienast, MD, Matthias Stelljes, MD

Blood (2009) 114 (22): 3317.

https://doi.org/10.1182/blood.V114.22.3317.3317

Published: 2009

Journal Articles

Clinical molecular imaging in intestinal graft-versus-host disease: mapping of disease activity, prediction, and monitoring of treatment efficiency by positron emission tomography

Matthias Stelljes, Sven Hermann, Jörn Albring, Gabriele Köhler, Markus Löffler, Christiane Franzius, Christopher Poremba, Verena Schlösser, Sarah Volkmann, Corinna Opitz, Christoph Bremer, Torsten Kucharzik, Gerda Silling, Otmar Schober, Wolfgang E. Berdel, Michael Schäfers, Joachim Kienast

Blood (2008) 111 (5): 2909–2918.

https://doi.org/10.1182/blood-2007-10-119164

Published: 2008

Includes: Multimedia, Supplemental data

Journal Articles

Forodesine in Patients with Refractory/Relapsed T-ALL Can Induce Prolonged Stable Remission with Minimal Toxicity before and after Allogeneic Hematopoietic Stem Cell Transplantation.

Mattias Stelljes, MD, Joachim Kienast, MD, Björna Berning, MD, Nicola Gokbuget, MD, Dieter Hoelzer, MD, Gerda Silling, MD, Wolfgang E. Berdel, MD, Gary Van Houten Dahl, MD, Debra Schissel, RN, Molly Hemenway, PNP, Lia Gore, MD

Blood (2006) 108 (11): 5340.

https://doi.org/10.1182/blood.V108.11.5340.5340

Published: 2006

Journal Articles

Noninvasive Assessment of Intestinal Graft-Versus-Host Disease Activity by 18F-Fluorodeoxyglucose Positron Emission Tomography.

Matthias Stelljes, MD, Jorn Albring, MD, Sven Hermann, MD, Christopher Poremba, MD, Gabiele Kohler, MD, Christoph Bremer, MD, Thorsten Kucharzik, MD, Gerda Silling, MD, Wolfgang E. Berdel, MD, Otmar Schober, MD, Michael Schafers, MD, Joachim Kienast, MD

Blood (2006) 108 (11): 3230.

https://doi.org/10.1182/blood.V108.11.3230.3230

Published: 2006

Journal Articles

Conditioning with 8 Gy Total Body Irradiation and Fludarabine for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia: Projected 4-Year Update.

Matthias Stelljes, MD, Martin Bornhaeuser, MD, Matthias Kroger, MD, Joerg Beyer, MD, Maria C. Sauerland, Achim Heinecke, PhD, Bjorna Berning, MD, Christian Scheffold, MD, Gerda Silling, MD, Thomas Buchner, MD, Andreas Neubauer, MD, Axel Arthur Fauser, MD, Gerhard Ehninger, MD, Wolfgang E. Berdel, MD, Joachim Kienast, MD

Blood (2006) 108 (11): 3016.

https://doi.org/10.1182/blood.V108.11.3016.3016

Published: 2006

Journal Articles

Conditioning with 8-Gy total body irradiation and fludarabine for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia

Matthias Stelljes, Martin Bornhauser, Matthias Kroger, Joerg Beyer, Maria C. Sauerland, Achim Heinecke, Bjorna Berning, Christian Scheffold, Gerda Silling, Thomas Buchner, Andreas Neubauer, Axel A. Fauser, Gerhard Ehninger, Wolfgang E. Berdel, Joachim Kienast, for the Cooperative German Transplant Study Group

Blood (2005) 106 (9): 3314–3321.

https://doi.org/10.1182/blood-2005-04-1377

Published: 2005

Journal Articles

Graft-versus-host disease after allogeneic hematopoietic stem cell transplantation induces a CD8 + T cell-mediated graft-versus-tumor effect that is independent of the recognition of alloantigenic tumor targets

Matthias Stelljes, Robert Strothotte, Hans-Gerd Pauels, Christopher Poremba, Michaela Milse, Christiane Specht, Jörn Albring, Guido Bisping, Christian Scheffold, Thomas Kammertoens, Elisabeth Oelmann, Gerda Silling, Wolfgang E. Berdel, Joachim Kienast

Blood (2004) 104 (4): 1210–1216.

https://doi.org/10.1182/blood-2003-10-3387

Published: 2004

NARROW

Targeting Interleukin-2 to the Bone Marrow Stroma for Therapy of Acute Myeloid Leukemia Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation

Control of Multidrug Resistant Pseudomonas Aeruginosa through Hospital Construction Design and Extensive Environmental and Clinical Surveillance in an Allogeneic Transplantat Unit

Comparison Of Different Pretransplant Predictive Scores In Patients With Refractory Acute Myeloid Leukemia After Allogeneic Stem Cell Transplantation Including Highdose Melphalan: Results Of a Double-Center Observational Study

Acute Myeloid Leukemia: Longterm Outcome Predicted by Age and Genetic Groups

Testing G-CSF responsiveness predicts the individual susceptibility to infection and consecutive treatment in recipients of high-dose chemotherapy

Dose Escalation of Caspofungin for Invasive Aspergillosis - A Phase II Trial

Forty-One Recent Cases of Invasive Zygomycosis From a Global Clinical Registry.

Immunological Intervention Triggered by Decreasing CD34 + Lineage-Specific Donor Cell Chimerism to Prevent Relapse of Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT).

Clinical molecular imaging in intestinal graft-versus-host disease: mapping of disease activity, prediction, and monitoring of treatment efficiency by positron emission tomography

Forodesine in Patients with Refractory/Relapsed T-ALL Can Induce Prolonged Stable Remission with Minimal Toxicity before and after Allogeneic Hematopoietic Stem Cell Transplantation.

Noninvasive Assessment of Intestinal Graft-Versus-Host Disease Activity by 18F-Fluorodeoxyglucose Positron Emission Tomography.

Conditioning with 8 Gy Total Body Irradiation and Fludarabine for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia: Projected 4-Year Update.

Conditioning with 8-Gy total body irradiation and fludarabine for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia

Graft-versus-host disease after allogeneic hematopoietic stem cell transplantation induces a CD8 + T cell-mediated graft-versus-tumor effect that is independent of the recognition of alloantigenic tumor targets

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only